The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Amelioration of hepatic fibrosis by NK cell activation
Abstract
Background and aims: Interactions between hepatic stellate cells (HSCs) and immune cell subsets have emerged as important determinants of liver fibrosis progression and regression. Natural killer (NK) cells have an antifibrotic activity through killing of activated HSCs. In liver injury NK cell expression of activating/inhibitory killer immunoglobulin-related receptors (aKIR/iKIR) and their ratio are significantly increased, while class I major histocompatibilty (MHC) expression by activated HSCs is decreased. The aim of this study was to amplify the antifibrotic activity of NK cells and ameliorate hepatic fibrosis by iKIR silencing. Methods: Human lymphocytes from patients with hepatitis C virus (HCV) infection were transfected with specific iKIR small interfering RNAs (siRNAs) or non-silencing control siRNAs, then co-cultured with a human HSC line and assessed for fibrogenic activity. To induce hepatic fibrosis, carbon tetrachloride was administrated to BALBc SCID-Beige male mice (lacking B/T/NK cells) for 4 weeks. Splenocytes from naive SCID donors (lacking B/T cells but with preserved NK cells) were transfected in vitro with either iKIR siRNA or non-silencing control siRNA, and then were transferred to the fibrotic SCID-Beige recipients. Results: Transfection with iKIR or positive control siRNAs (mice and human) decreased mRNA expression of iKIR and mitogen-acivated protein kinase 1 (MAPK1). Consequently, total NK cells and NK cell degranulation were increased (p=0.01), consistent with NK cell stimulation. Compared with healthy lymphocytes, when HCV lymphocytes were transfected with non-silencing control siRNA and co-cultured with HSCs there was increased α-smooth muscle actin (αSMA) expression, reflecting HSC activation. Expression of αSMA in co-cultures was attenuated when HCV lymphocytes were transfected with iKIR siRNA. In SCID-Beige recipients, hepatic fibrosis and serum alanine aminotransferase (ALT) levels were significantly attenuated as a result of receiving iKIR siRNA. Conclusions: iKIR knockdown stimulates NK cells and promotes their antifibrogenic activity in mice and human co-cultures. These findings have implications for possible immune therapeutic strategies in patients with advanced liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Natural killer (NK) cells have an intriguing capacity to clear activated HSCs (91-94).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Safadi, R., Zigmond, E., Pappo, O., Shalev, Z., & llan, Y. (2007) · International Immunology · doi:10.1093/intimm/dxm069 · Cited by 35
Self-citationRetractedBataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,773
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J., & Altfeld, M. A. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,416
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D., Dunbar, P. R., Chapman, R. W., Chung, R. T., Dohrenwend, P. B., Robbins, G. K., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
Xu, L., Hui, A. Y., Albanis, E., Arthur, M. J., O’Byrne, S. M., Blaner, W. S., Mukherjee, P., Friedman, S. L., & Eng, F. J. (2004) · Gut · doi:10.1136/gut.2004.042127 · Cited by 1,020
Self-citationREGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 936
Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., & Gao, B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.055 · Cited by 610
Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic
Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., & Gores, G. J. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069036.63405.5c · Cited by 417 · cited 1×
“Reduction of activation was achieved when LX2 cells were cultured to confluence in 6-well flasks (Nunc Brand Products, Roskilde, Denmark) with 1% fetal calf serum (FCS).(11) Healthy and HCVderived peripheral blood lymphocytes (PBLs) were co-cultured for 48 h with LX2 cells.”
MethodSelf-citationFriedman, S. L., & Arthur, M. J. P. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114362 · Cited by 404
Self-citation
Research works printed but not linked: 1
- 10.1172/JCI200524282 · DOI · Paper page
Cited by
Sorted by citations
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923
Self-citationHepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
Fu, Y., Liu, S., Zeng, S., & Shen, H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1396-4 · Cited by 395
Aydin, M. M., & Akçalı, K. C. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17330 · Cited by 397
Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K. L., Tacke, F., Tolba, R. H., Trautwein, C., Trebicka, J., & Weiskirchen, R. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-19 · Cited by 346
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Li, T., Yang, Y., Hua, X., Wang, G., Liu, W., Jia, C., Tai, Y., Zhang, Q., & Chen, G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.020 · Cited by 345
Natural killer cells in liver disease
Tian, Z., Chen, Y., & Gao, B. (2012) · Hepatology · doi:10.1002/hep.26115 · Cited by 306
Wehr, A., Baeck, C., Heymann, F., Niemietz, P. M., Hammerich, L., Martin, C., Zimmermann, H. W., Pack, O., Gassler, N., Hittatiya, K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202909 · Cited by 268
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236
Chronic hepatitis C and liver fibrosis
Sebastiani, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11033 · Cited by 242
Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy
Orman, E. S., Òdena, G., & Bataller, R. A. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12030 · Cited by 233
Innate immunity in alcoholic liver disease
Gao, B., Seki, E., Brenner, D. A., Friedman, S. L., Cohen, J. I., Nagy, L. E., Szabó, G., & Zakhari, S. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00537.2010 · Cited by 231
Self-citationInnate immune cells in cirrhosis
Bernsmeier, C., der Merwe, V., & Périanin, A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.027 · Cited by 211
Management Strategies for Liver Fibrosis
Altamirano-Barrera, A., Barranco-Fragoso, B., & Méndez‐Sánchez, N. (2016) · Annals of Hepatology · doi:10.5604/16652681.1226814 · Cited by 195
Liver natural killer cells: subsets and roles in liver immunity
Peng, H. C., Wisse, E., & Tian, Z. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.96 · Cited by 192
NKp46-Mediated Killing of Human and Mouse Hepatic Stellate Cells Attenuates Liver Fibrosis
Gur, C., Doron, S., Kfir-Erenfeld, S., Horwitz, E., Abu-tair, L., Safadi, R., & Mandelboim, O. (2012) · Gut · doi:10.1136/gutjnl-2011-301400 · Cited by 173
Self-citationIntercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy
Cai, X., Wang, J., Wang, J., Zhou, Q., Yang, B., He, Q., & Weng, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104720 · Cited by 170
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
Self-citationNatural killer and natural killer T cells in liver fibrosis
Gao, B., & Radaeva, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.008 · Cited by 165
Glässner, A., Eisenhardt, M., Krämer, B., Körner, C., Coenen, M., Sauerbruch, T., Spengler, U., & Nattermann, J. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.54 · Cited by 157
Hepatic Stellate Cells and Hepatocarcinogenesis
Barry, A. E., Baldeosingh, R., Lamm, R. J., Patel, K., Zhang, K., Dominguez, D. A., Kirton, K. J., Shah, A. P., & Dang, H. T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00709 · Cited by 159
Mesenchymal stromal cells promote liver regeneration through regulation of immune cells
Hu, C., Wu, Z., & Li, L. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.39725 · Cited by 154
Reversal of liver cirrhosis: current evidence and expectations
Jung, Y. K., & Yim, H. J. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.268 · Cited by 163
Jeong, W.-I., Park, O., Suh, Y.-G., Byun, J.-S., Park, S.-Y., Choi, E., Kim, J.-K., Ko, H., Wang, H., Miller, A. M., et al. (2011) · Hepatology · doi:10.1002/hep.24190 · Cited by 142
Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment
Berenguer, M., & Schuppan, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.014 · Cited by 146
Zhang, D., Jiang, M., & Miao, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016789 · Cited by 139
Krämer, B., Körner, C., Kebschull, M., Glässner, A., Eisenhardt, M., Nischalke, H. D., Alexander, M., Sauerbruch, T., Spengler, U., & Nattermann, J. (2012) · Hepatology · doi:10.1002/hep.25804 · Cited by 129
Sun, H. Q., Zhang, J., Zhang, H., Zou, Z., Wang, F. S., & Jia, J. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01561.x · Cited by 121
Natural killer cells and liver fibrosis
Fasbender, F., Widera, A., Hengstler, J. G., & Watzl, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00019 · Cited by 118
Diversity of tissue-resident NK cells
Peng, H. C., & Tian, Z. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.006 · Cited by 113
Natural killer cells in inflammatory heart disease
Ong, S., Rose, N. R., & Čiháková, D. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.11.010 · Cited by 109
Cellular basis of hepatic fibrosis and its role in inflammation and cancer
Kocabayoglu, P. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s368 · Cited by 101
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
Self-citationNatural killer cells: multifaceted players with key roles in hepatitis C immunity
Golden‐Mason, L., & Rosen, H. R. (2013) · Immunological Reviews · doi:10.1111/imr.12090 · Cited by 86
Luo, Z., Shivakumar, P., Mourya, R., Gutta, S., & Bezerra, J. A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.017 · Cited by 83
Antifibrotic Therapies in the Liver
Schuppan, D., & Mehal, W. Z. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1550055 · Cited by 76
Cancer-associated fibroblasts in digestive tumors
Huang, L., Xu, A., Liu, S., Liu, W., & Li, T.-J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17804 · Cited by 77
Langhans, B., Alwan, A. W., Krämer, B., Glässner, A., Lutz, P. L., Strassburg, C. P., Nattermann, J., & Spengler, U. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.038 · Cited by 73
Common genetic variation in vitamin D metabolism is associated with liver stiffness
Grünhage, F., Hochrath, K., Krawczyk, M. J., Höblinger, A., Obermayer-Pietsch, B. M., Geisel, J., Trauner, M. A., Sauerbruch, T., & Lammert, F. (2012) · Hepatology · doi:10.1002/hep.25830 · Cited by 71
The immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
Martínez-Chantar, M. L., Delgado, T. C., & Beraza, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640869 · Cited by 67
Yi, H., Lee, Y., Byun, J.-S., Seo, W., Jeong, J., Park, O., Duester, G., Haseba, T., Kim, S. C., Park, K. G., et al. (2014) · Hepatology · doi:10.1002/hep.27137 · Cited by 67
Shi, J., Zhao, J., Zhang, X., Cheng, Y., Hu, J., Li, Y., Zhao, X., Shang, Q., Sun, Y., Tu, B., et al. (2017) · Scientific Reports · doi:10.1038/srep44544 · Cited by 66
Choi, W., Ryu, T., Lee, J. H., Shim, Y., Kim, M., Kim, H., Kim, Y. E., Yang, K., Kim, K., Choi, S. E., et al. (2021) · Hepatology · doi:10.1002/hep.31875 · Cited by 60
van Dijk, F., Olinga, P., Poelstra, K., & Beljaars, L. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00072 · Cited by 60
Lee, H. W., Cho, K. J., & Park, J. Y. (2020) · Immune Network · doi:10.4110/in.2020.20.e11 · Cited by 57
The Space of Disse: The Liver Hub in Health and Disease
Sanz-García, C., Fernández-Iglesias, A., Gracia-Sancho, J., Arráez-Aybar, L. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Livers · doi:10.3390/livers1010002 · Cited by 57
Peng, Y. Y., Yang, T., Huang, K., Shen, L., Tao, Y., & Liu, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00762 · Cited by 55
Meyer, M., Schwärzler, J., Jukic, A., & Tilg, H. (2024) · Biomolecules · doi:10.3390/biom14040476 · Cited by 50
Natural killer T cells in liver injury, inflammation and cancer
Wang, H., & Yin, S. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1056738 · Cited by 47
Liver fibrogenesis and metabolic factors
Anty, R., & Lemoine, M. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(11)70003-1 · Cited by 47
Zhou, X., Yu, L., Zhou, M., Hou, P., Yi, L., & Mi, M. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00589-6 · Cited by 47
Eisenhardt, M., Glässner, A., Krämer, B., Körner, C., Sibbing, B., Kokordelis, P., Nischalke, H. D., Sauerbruch, T., Spengler, U., & Nattermann, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038846 · Cited by 46
Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Liver Fibrosis in Rats
Kubo, K., Ohnishi, S., Hosono, H., Fukai, M., Kameya, A., Higashi, R., Yamada, T., Onishi, R., Yamahara, K., Takeda, H., et al. (2015) · Transplantation Direct · doi:10.1097/txd.0000000000000525 · Cited by 43
Wang, X. M., Holz, L. E., Chowdhury, S., Cordoba, S. P., Evans, K., Gall, M. G., de Ribeiro, A. J. V., Zheng, Y. Z., Levy, M. T., Yu, D. M. T., et al. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.116 · Cited by 42
Insulin Signaling as a Potential Natural Killer Cell Checkpoint in Fatty Liver Disease
Amer, J., Salhab, A., Noureddin, M., Doron, S., Abu‐Tair, L., Ghantous, R., Mahamid, M., & Safadi, R. (2018) · Hepatology Communications · doi:10.1002/hep4.1146 · Cited by 42
Self-citationLi, T., Yang, Y., Song, H., Li, H., Cui, A., Liu, Y., Su, L., Crispe, I. N., & Tu, Z. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a0118-031rr · Cited by 41
New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article
Ebrahimi, H., Naderian, M., & Sohrabpour, A. A. (2018) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2018.103 · Cited by 41
Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review)
Zhang, Y., Wu, Y., Shen, W., Wang, B., & Yuan, X. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12724 · Cited by 35
Insights on drug and gene delivery systems in liver fibrosis
Vyas, K., & Patel, M. M. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100779 · Cited by 30
Duman, D., Zibandeh, N., Uğurlu, M. Ü., Çelikel, Ç., Akkoç, T., Banzragch, M., Genç, D., Özdogan, O. C., & Akkoç, T. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04736-4 · Cited by 31
Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy
Li, H., & Zhang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.12101 · Cited by 29
Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9
Abu-Tair, L., Axelrod, J. H., Doron, S., Ovadya, Y., Krizhanovsky, V., Galun, E., Amer, J., & Safadi, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082571 · Cited by 28
Self-citationNatural Killer Cells in Liver Disease
Stegmann, K. A., Easom, N. J. W., Maini, M. K., & Male, V. H. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1603946 · Cited by 27
Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis
Wan, M., Han, J., Ding, L., Hu, F., & Gao, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.604894 · Cited by 27
The antifibrotic role of natural killer cells in liver fibrosis
Wei, Y., Bingyu, W., Yang, L., & Yuan, X. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221092672 · Cited by 27
Role of immune cells in the pathogenesis of myocarditis
Liu, K., & Han, B. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad143 · Cited by 34
NK Cells Prevalence, Subsets and Function in Viral Hepatitis C
Zeromski, J., Mozer‐Lisewska, I., Kaczmarek, M., Kowala-Piaskowska, A. E., & Sikora, J. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0145-y · Cited by 26
Intrahepatic NK cells function suppressed in advanced liver fibrosis
Li, X., Zhang, M., Liu, J., Huang, Z., Zhao, Q., Huang, Y., Li, X., & Gao, Z. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12669 · Cited by 23
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention
Rabiu, L., Zhang, P., Afolabi, L. O., Saliu, M. A., Dabai, S. M., Suleiman, R. B., Gidado, K. I., Ige, M. A., Ibrahim, A., Zhang, G., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02157-0 · Cited by 24
Altomonte, J., Marozin, S., Toni, E. N. D., Rizzani, A., Esposito, I., Steiger, K., Feuchtinger, A., Hellerbrand, C., Schmid, R. M., & Ebert, O. (2013) · Molecular Therapy · doi:10.1038/mt.2013.181 · Cited by 22
The Important Roles of Natural Killer Cells in Liver Fibrosis
Yang, M. J., Vanderwert, E., Kimchi, E. T., Staveley-O’Carroll, K. F., & Li, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051391 · Cited by 22
Seydel, G. Ş., Beilfuss, A., Kahraman, A., Aksoy, K., Gerken, G., Akkız, H., & Canbay, A. E. (2011) · The Turkish Journal of Gastroenterology · doi:10.4318/tjg.2011.0254 · Cited by 21
Baligar, P., Mukherjee, S., Kochat, V., Rastogi, A., & Mukhopadhyay, A. (2015) · Stem Cells · doi:10.1002/stem.2210 · Cited by 20
Moriya, K., Nishimura, N., Namisaki, T., Takaya, H., Sawada, Y., Kawaratani, H., Kaji, K., Shimozato, N., Sato, S., Furukawa, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112465 · Cited by 18
Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
Wu, M., Zhou, Y., Qin, S.-L., Lin, L., Jian, P., Zhang, T., Zhang, J., Xu, L., & Wu, J. H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3468791 · Cited by 20
Immunopathogenesis of Hepatitis C Virus Infection
Kaplan, D. E. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.07.004 · Cited by 18
Polo, M. L., Ghiglione, Y., Salido, J., Urioste, A., Poblete, G., Sisto, A. E., Martinez, A., Rolón, M. J., Ojeda, D. S., Cahn, P. E., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25375 · Cited by 17
Roles of innate lymphoid cells in metabolic and alcohol-associated liver diseases
Bourinet, M., Anty, R., Gual, P., & Luci, C. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100962 · Cited by 20
Shin, S. K., Oh, S., Chun, S., Ahn, M., Lee, S., Kim, K.-S., Kang, H., Lee, J., Shin, S. P., Lee, J., et al. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16584 · Cited by 15
Role of altered immune cells in liver diseases: a review.
Wahid, B., Ali, A., Rafique, S., Saleem, K., Waqar, M., Wasim, M., & Idrees, M. (2018) · Gastroenterology & hepatology · doi:10.1016/j.gastrohep.2018.01.014 · Cited by 13
Ren, Y., Li, H., Zhou, L., Lu, Z., Shi, J., Geng, Y., & Xu, Z. (2020) · Nutrients · doi:10.3390/nu12092778 · Cited by 13
Zimmermann, H. W., Mueller, J. R., Seidler, S., Luedde, T., Trautwein, C., & Tacke, F. (2013) · Digestion · doi:10.1159/000350821 · Cited by 12
Enhanced activation of human NK cells by drug-exposed hepatocytes
Fasbender, F., Obholzer, M., Metzler, S., Stöber, R. M., Hengstler, J. G., & Watzl, C. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02668-8 · Cited by 12
Impaired circulating CD56dim NK cells are associated with decompensation of HBV-related cirrhosis
Jiang, Y., Chen, Y., Chen, L., Yao, W., Guan, J., Liu, X., Wei, X., & Lin, X. (2019) · Human Immunology · doi:10.1016/j.humimm.2019.11.006 · Cited by 10
Momtazi, M., Ding, J., Kwan, P. O., Anderson, C. C., Honardoust, D., Goekjian, S. R., & Tredget, E. E. (2015) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000001782 · Cited by 10
Ambiguous roles of innate lymphoid cells in chronic development of liver diseases
Shen, Y. L., Li, J., Wang, S., & Jiang, W. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i18.1962 · Cited by 10
Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases
Handa, P., & Kowdley, K. V. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30918-4 · Cited by 10
Avraham, Y., Amer, J., Doron, S., Abu-Tair, L., Mahamid, M., Khatib, A., Berry, E. M., & Safadi, R. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00191.2011 · Cited by 9
Self-citationZhou, P., Yang, L., Li, H., Zeng, L., Zhang, Y., Zhong, Z., Li, R., Yin, Y., Tao, K., & Zhang, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113945 · Cited by 9
Hotho, D. M., Kreefft, K., Groothuismink, Z. M. A., Janssen, H. L. A., de Knegt, R. J., & Boonstra, A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2012.12.025 · Cited by 7
Transforming Growth Factor-β Signaling in Alcohol-Associated Liver Disease
Zou, H., Wang, S., Huang, C., Dooley, S., & Meindl‐Beinker, N. M. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.09.017 · Cited by 7
Ceccherini, E., Cecchettini, A., Morales, M. A., & Rocchiccioli, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00813 · Cited by 6
Bioreactor-based stem cell therapy for liver fibrosis
Yan, M., Yao, J., Xie, Y., Jiang, P., Yan, J., & Li, X. (2024) · Biofabrication · doi:10.1088/1758-5090/ad304d · Cited by 5
Interactions of Stellate Cells with Other Non-Parenchymal Cells
Kawada, N., & Parola, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00012-9 · Cited by 5
Characteristics of peripheral and intrahepatic regulatory B cells in HBV-related liver cirrhosis.
Xiong, Y., Wu, H., Li, Y., Huang, R., Liu, Y., Chen, Y., Zhao, X., Chang, H., Chen, J., & Wu, C. (2018) · Europe PMC (PubMed Central) · Cited by 4
Ma, Y., Ping, D.-B., Huang, K., Tao, Y., Peng, Y., Sun, X., & Liu, C.-H. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.110775 · Cited by 4
The Immune Interplay between Thyroid Papillary Carcinoma and Hepatic Fibrosis
Muhanna, N., Amer, J., Salhab, A., Sichel, J., & Safadi, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132463 · Cited by 3
Self-citation
Metadata
- Authors
- Muhanna, N., Tair, L. A., Doron, S., Amer, J., Azzeh, M., Mahamid, M., Friedman, S., & Safadi, R.
- Affiliations
- Hadassah Medical Center (IL)
- Al-Quds University (PS)
- Corresponding author
- Safadi, Rifaat
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2010-07-26
- Volume
- 60
- Issue
- 1
- Pages
- 90-98
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2102422505
- Cited by
- 127
- References
- 25
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 2 · 2021: 11 · 2020: 12 · 2019: 8 · 2018: 8 · 2017: 4 · 2016: 9 · 2015: 11 · 2014: 9 · 2013: 14 · 2012: 10
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, natural killer cells, hepatic stellate cells, NK cell activation, antifibrotic activity, hepatitis C virus, siRNA knockdown, NK cell degranulation, MAPK1, alpha-smooth muscle actin, liver injury, carbon tetrachloride
- MeSH terms
- Animals, Cells, Cultured, Humans, Killer Cells, Natural, Liver Cirrhosis, Liver Cirrhosis, Experimental, Lymphocyte Activation, Male, Mice, Inbred BALB C, Middle Aged, RNA, Messenger, Spleen, Genetic Therapy, Mice, SCID, Coculture Techniques, Adoptive Transfer, RNA, Small Interfering, Mice, Receptors, KIR, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
